
TECH
NGSBio-Techne Corp
Healthcare•Biotechnology
Watchlists:
Last updated: Monday 21st July 2025
52.02
-1.27 (-2.38%)
Prev Close:53.29
Open:53.71
Bid:50.8
Ask:52.55
52 Week Range
46.0183.62
Volume:2,210,595
Mkt Cap:8,061 M
46
MarketXLS Rank ®
Hold
Price Target
$59.82
+15.0%
Financial Statements
TECH - Income Statement (Annual)
Jun-24 | Jun-23 | Jun-22 | Jun-21 | Jun-20 | Jun-19 | Jun-18 | Jun-17 | Jun-16 | Jun-15 | |
---|---|---|---|---|---|---|---|---|---|---|
Acquisition Expense | 7 M | -10 M | -19 M | 7 M | ||||||
Depreciation And Amortization | 43 M | 37 M | ||||||||
Earnings From Equity Interest | -7 M | 12 M | ||||||||
Earnings From Equity Interest Net Of Tax | -7 M | 12 M | ||||||||
Gain On Sale Of Security | 3 M | 3 M | 794000.0 | 473000.0 | 605000.0 | 569000.0 | 409000.0 | 304000.0 | 249000.0 | 634000.0 |
General And Administrative Expense | 466 M | 378 M | 373 M | 325 M | 261 M | 264 M | 241 M | 200 M | 141 M | 119 M |
Gross Profit Margin (profit Margin After CGS) | 770 M | 770 M | 756 M | 633 M | 483 M | 473 M | 432 M | 375 M | 337 M | 307 M |
Impairment Of Capital Assets | 19 M | |||||||||
Interest Expense Non Operating | 11 M | 11 M | 14 M | 19 M | 22 M | 10 M | 7 M | 2 M | 2 M | |
Interest Expense Operating | -15 M | -8 M | -11 M | -14 M | -19 M | -21 M | -10 M | -7 M | -2 M | |
Minority Interests | -179000.0 | 9 M | 825000.0 | 1,381 M | ||||||
Misc Other Special Charges | -9 M | 48 M | 15 M | -76 M | 138 M | -14 M | -447000.0 | -2 M | -2 M | 8 M |
Net Income (loss) | 168 M | 285 M | 272 M | 140 M | 229 M | 96 M | 126 M | 76 M | 104 M | 108 M |
Net Income Common Stockholders | 168 M | 285 M | 272 M | 140 M | 229 M | 96 M | 126 M | 76 M | 104 M | 108 M |
Net Income Continuous Operations | 168 M | 285 M | 263 M | 140 M | 229 M | 96 M | 126 M | 76 M | 104 M | 108 M |
Net Non Operating Interest Income Expense | 8 M | 11 M | -14 M | -19 M | -22 M | -10 M | -7 M | -2 M | -2 M | |
Non Recurring Operation Expense | 4 M | |||||||||
Normalized Income | 207 M | 124 M | 218 M | 88 M | 100 M | -591 M | 92 M | |||
Operating Income | 207 M | 299 M | 297 M | 237 M | 157 M | 147 M | 136 M | 121 M | 151 M | 147 M |
Operating Income Before Depreciation (EBITDA) | 297 M | 446 M | 414 M | 250 M | 378 M | 190 M | 191 M | 172 M | 190 M | 193 M |
Operating Expense | 563 M | 471 M | 461 M | 396 M | 326 M | 327 M | 296 M | 254 M | 186 M | 160 M |
Other Gand A | 466 M | 378 M | 373 M | 325 M | 261 M | 264 M | 241 M | 200 M | 141 M | 119 M |
Other Operating Expenses | 18 M | 16 M | 14 M | -306000.0 | -2 M | -35000.0 | -13000.0 | |||
Promotion And Advertising | 4 M | 5 M | 5 M | 5 M | 4 M | 4 M | 4 M | 5 M | 5 M | 4 M |
Rent And Landing Fees | 13 M | 11 M | 10 M | 8 M | 5 M | |||||
Research Expense | 97 M | 92 M | 87 M | 71 M | 65 M | 62 M | 55 M | 54 M | 45 M | 41 M |
Restructring And Mn A Income | 12 M | 4 M | 2 M | 142000.0 | 376000.0 | -99 M | -111 M | -104 M | ||
Salaries And Wages | -18 M | -12 M | -29 M | -400000.0 | -500000.0 | |||||
Selling And Marketing Expense | 4 M | 5 M | 5 M | 5 M | 4 M | 4 M | 4 M | 5 M | 5 M | 4 M |
Total Income Available For Interest Expense (EBIT) | 186 M | 339 M | 313 M | 162 M | 296 M | 112 M | 126 M | 112 M | 148 M | 156 M |
Total Revenues | 1,159 M | 1,137 M | 1,106 M | 931 M | 739 M | 714 M | 643 M | 563 M | 499 M | 452 M |
Total Expenses | 952 M | 838 M | 810 M | 694 M | 581 M | 567 M | 507 M | 442 M | 348 M | 305 M |
Total Revenue | 1,159 M | 1,137 M | 1,106 M | 931 M | 739 M | 714 M | 643 M | 563 M | 499 M | 452 M |
Amord | 973 M | 873 M | 822 M | 843 M | 728 M | 733 M | 598 M | 579 M | 431 M | 391 M |
Avgshs | 158 M | 157 M | 157 M | 155 M | 153 M | 151 M | 150 M | 149 M | 149 M | 148 M |
Avgshsdt | 161 M | 162 M | 164 M | 162 M | 158 M | 156 M | 152 M | 150 M | 149 M | 149 M |
Basiceps | 1.07 | 1.81 | 1.73 | 0.91 | 1.5 | 0.64 | 0.84 | 0.51 | 0.7 | 0.73 |
Basicepscont | 1.07 | 1.81 | 1.73 | 0.91 | 1.5 | 0.64 | 0.84 | 0.51 | 0.7 | 0.73 |
Cor | 389 M | 367 M | 349 M | 298 M | 255 M | 241 M | 211 M | 188 M | 162 M | 145 M |
Depamor | 43 M | 37 M | ||||||||
Dileps | 1.05 | 1.76 | 1.66 | 0.87 | 1.46 | 0.62 | 0.83 | 0.51 | 0.7 | 0.72 |
Dilepscont | 1.05 | 1.76 | 1.66 | 0.87 | 1.46 | 0.62 | 0.83 | 0.51 | 0.7 | 0.72 |
Div Per Share | 0.32 | 0.32 | 0.32 | 0.32 | 0.32 | 0.32 | 0.32 | 0.32 | 0.32 | 0.32 |
Netincdisc | 168 M | 285 M | 272 M | 140 M | 229 M | 96 M | 126 M | 76 M | 104 M | 108 M |
Othincexp | 5 M | -51 M | 16 M | 75 M | -138 M | 13 M | 38000.0 | 1 M | 1 M | -9 M |
Pretaxinc | 186 M | 339 M | 301 M | 148 M | 276 M | 112 M | 126 M | 112 M | 147 M | 154 M |
Resdev | 97 M | 92 M | 87 M | 71 M | 65 M | 62 M | 55 M | 54 M | 45 M | 41 M |
Restruct | 12 M | 4 M | 2 M | 142000.0 | 376000.0 | -99 M | -111 M | -104 M | ||
Sga | 466 M | 378 M | 373 M | 325 M | 261 M | 264 M | 241 M | 200 M | 141 M | 119 M |
Shsout | 159 M | 157 M | 157 M | 156 M | 154 M | 152 M | 151 M | 150 M | 149 M | 149 M |
Specincchg | -16 M | -4 M | -20 M | -142000.0 | -376000.0 | 99 M | 111 M | 104 M | ||
Taxprov | 18 M | 53 M | 38 M | 9 M | 47 M | 16 M | -198000.0 | 36 M | 43 M | 46 M |